.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Deloitte
Julphar
Accenture
Citi
Daiichi Sankyo
Colorcon
Cipla
US Department of Justice
Johnson and Johnson

Generated: June 22, 2017

DrugPatentWatch Database Preview

Flurandrenolide; neomycin sulfate - Generic Drug Details

« Back to Dashboard

What are the generic sources for flurandrenolide; neomycin sulfate and what is the scope of flurandrenolide; neomycin sulfate patent protection?

Flurandrenolide; neomycin sulfate
is the generic ingredient in one branded drug marketed by Lilly and is included in two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for flurandrenolide; neomycin sulfate.

Summary for Generic Name: flurandrenolide; neomycin sulfate

Tradenames:1
Patents:1
Applicants:1
NDAs:2
Drug Master File Entries: see list4
Clinical Trials: see list652
Drug Prices:see low prices
DailyMed Link:flurandrenolide; neomycin sulfate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
CORDRAN N
flurandrenolide; neomycin sulfate
OINTMENT;TOPICAL050345-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Lilly
CORDRAN N
flurandrenolide; neomycin sulfate
CREAM;TOPICAL050346-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Fuji
Mallinckrodt
Cerilliant
Medtronic
Chubb
Boehringer Ingelheim
Argus Health
AstraZeneca
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot